113 related articles for article (PubMed ID: 17021051)
1. An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase eta.
Arena S; Pattarozzi A; Massa A; Esteve JP; Iuliano R; Fusco A; Susini C; Florio T
Mol Endocrinol; 2007 Jan; 21(1):229-46. PubMed ID: 17021051
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1).
Florio T; Yao H; Carey KD; Dillon TJ; Stork PJ
Mol Endocrinol; 1999 Jan; 13(1):24-37. PubMed ID: 9892010
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2.
Florio T; Thellung S; Arena S; Corsaro A; Bajetto A; Schettini G; Stork PJ
J Physiol Paris; 2000; 94(3-4):239-50. PubMed ID: 11088001
[TBL] [Abstract][Full Text] [Related]
4. The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2.
Massa A; Barbieri F; Aiello C; Iuliano R; Arena S; Pattarozzi A; Corsaro A; Villa V; Fusco A; Zona G; Spaziante R; Schettini G; Florio T
Ann N Y Acad Sci; 2004 Dec; 1030():264-74. PubMed ID: 15659806
[TBL] [Abstract][Full Text] [Related]
5. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
[TBL] [Abstract][Full Text] [Related]
6. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
7. Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation.
Ferjoux G; Lopez F; Esteve JP; Ferrand A; Vivier E; Vely F; Saint-Laurent N; Pradayrol L; Buscail L; Susini C
Mol Biol Cell; 2003 Sep; 14(9):3911-28. PubMed ID: 12972574
[TBL] [Abstract][Full Text] [Related]
8. The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue.
Pera IL; Iuliano R; Florio T; Susini C; Trapasso F; Santoro M; Chiariotti L; Schettini G; Viglietto G; Fusco A
Oncogene; 2005 Apr; 24(19):3187-95. PubMed ID: 15735685
[TBL] [Abstract][Full Text] [Related]
9. The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling.
Lopez F; Estève JP; Buscail L; Delesque N; Saint-Laurent N; Théveniau M; Nahmias C; Vaysse N; Susini C
J Biol Chem; 1997 Sep; 272(39):24448-54. PubMed ID: 9305905
[TBL] [Abstract][Full Text] [Related]
10. The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells.
Florio T; Rim C; Hershberger RE; Loda M; Stork PJ
Mol Endocrinol; 1994 Oct; 8(10):1289-97. PubMed ID: 7854346
[TBL] [Abstract][Full Text] [Related]
11. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.
Wu DW; Stark KC; Dunnington D; Dillon SB; Yi T; Jones C; Pelus LM
Blood Cells Mol Dis; 2000 Feb; 26(1):15-24. PubMed ID: 10772872
[TBL] [Abstract][Full Text] [Related]
12. sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation.
Lahlou H; Saint-Laurent N; Estève JP; Eychène A; Pradayrol L; Pyronnet S; Susini C
J Biol Chem; 2003 Oct; 278(41):39356-71. PubMed ID: 12878607
[TBL] [Abstract][Full Text] [Related]
13. sst2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1.
Bousquet C; Delesque N; Lopez F; Saint-Laurent N; Estève JP; Bedecs K; Buscail L; Vaysse N; Susini C
J Biol Chem; 1998 Mar; 273(12):7099-106. PubMed ID: 9507021
[TBL] [Abstract][Full Text] [Related]
14. Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases.
Leung KC; Brce J; Doyle N; Lee HJ; Leong GM; Sjögren K; Ho KK
Endocrinology; 2007 May; 148(5):2417-23. PubMed ID: 17272397
[TBL] [Abstract][Full Text] [Related]
15. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
[TBL] [Abstract][Full Text] [Related]
16. Neuronal nitric oxide synthase: a substrate for SHP-1 involved in sst2 somatostatin receptor growth inhibitory signaling.
Lopez F; Ferjoux G; Cordelier P; Saint-Laurent N; Estève JP; Vaysse N; Buscail L; Susini C
FASEB J; 2001 Oct; 15(12):2300-2. PubMed ID: 11511520
[TBL] [Abstract][Full Text] [Related]
17. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.
Nakamura K; Cambier JC
J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin/somatostatin receptor signalling: phosphotyrosine phosphatases.
Florio T
Mol Cell Endocrinol; 2008 May; 286(1-2):40-8. PubMed ID: 17913342
[TBL] [Abstract][Full Text] [Related]
19. [The activation of the phosphotyrosine phosphatase eta is responsible for the somatostatin inhibition of PCCl3 thyroid cell proliferation].
Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Villa V; Pattarozzi A; Diana F; Fusco A; Schettini G
Minerva Endocrinol; 2001 Dec; 26(4):277-83. PubMed ID: 11782716
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2.
Barbieri F; Pattarozzi A; Gatti M; Porcile C; Bajetto A; Ferrari A; Culler MD; Florio T
Endocrinology; 2008 Sep; 149(9):4736-46. PubMed ID: 18566118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
